Publications by authors named "Mari Gilljam"

Claim this Profile
C
Challenges in αCD38-chimeric antigen receptor (CAR)-expressing natural killer (NK) cell-based immunotherapy in multiple myeloma: Harnessing the CD38dim phenotype of cytokine-stimulated NK cells as a strategy to prevent fratricide.
Maria Karvouni, Marcos Vidal-Manrique, Katharina H Susek, Alamdar Hussain, Mari Gilljam

Cytotherapy· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy.
Katharina H Susek, Ysabel A Schwietzer, Maria Karvouni, Mari Gilljam, Marton Keszei

Cancer Immunol Immunother· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma.
Hareth Nahi, Michael Chrobok, Stephan Meinke, Charlotte Gran, Nicole Marquardt, Mari Gilljam

Cell Rep Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells.
Michael Chrobok, Carin I M Dahlberg, Ece Canan Sayitoglu, Vladimir Beljanski, Hareth Nahi, Mari Gilljam

Cancers (Basel)· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data.
José Paulo Martins, Jorge Miguel Santos, Joana Marto de Almeida, Mariana Alves Filipe, Mariana Vargas Teixeira de Almeida, Mari Gilljam

Stem Cell Res Ther· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of intracellular antiviral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy.
Tolga Sutlu, Sanna Nyström, Mari Gilljam, Birgitta Stellan, Steven E Applequist

Hum Gene Ther· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor.
Tolga Sutlu, Birgitta Stellan, Mari Gilljam, Hernan Concha Quezada, Hareth Nahi

Cytotherapy· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study.
Lisbeth Barkholt, Evren Alici, Reka Conrad, Tolga Sutlu, Mari Gilljam

Immunotherapy· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components.
Evren Alici, Tolga Sutlu, Bo Björkstrand, Mari Gilljam, Birgitta Stellan

Blood· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis